Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading down 29 points (-0.2%) at 16,367 as of Wednesday, March 5, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,229 issues advancing vs. 1,681 declining with 174 unchanged. The Diversified Services industry currently sits down 0.2% versus the S&P 500, which is unchanged. On the negative front, top decliners within the industry include Verisk Analytics ( VRSK), down 1.3%, Fidelity National Information Services ( FIS), down 1.2%, Fiserv ( FISV), down 1.1%, Paychex ( PAYX), down 1.0% and Visa ( V), down 1.0%. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. AthenaHealth ( ATHN) is one of the companies pushing the Diversified Services industry lower today. As of noon trading, AthenaHealth is down $9.56 (-4.7%) to $194.85 on light volume. Thus far, 214,904 shares of AthenaHealth exchanged hands as compared to its average daily volume of 685,800 shares. The stock has ranged in price between $194.35-$203.56 after having opened the day at $202.77 as compared to the previous trading day's close of $204.41. athenahealth, Inc., a business services company, provides ongoing billing, clinical-related, and other related services to medical group practices primarily in the United States. The company provides services through the athenaNet, a proprietary Internet-based practice management application. AthenaHealth has a market cap of $7.3 billion and is part of the technology sector. Shares are up 45.0% year-to-date as of the close of trading on Tuesday. Currently there are 8 analysts that rate AthenaHealth a buy, 2 analysts rate it a sell, and 12 rate it a hold. TheStreet Ratings rates AthenaHealth as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and premium valuation. Get the full AthenaHealth Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.